Natural Flt3Lg-Based Chimeric Antigen Receptor (Flt3-CAR) T Cells Successfully Target Flt3 on AML Cell Lines

Código QR

Natural Flt3Lg-Based Chimeric Antigen Receptor (Flt3-CAR) T Cells Successfully Target Flt3 on AML Cell Lines

Relapsed/refractory acute myeloid leukemia (AML) cannot be cured with chemotherapy alone, as the blasts survive the treatment. Chimeric antigen receptor (CAR) approaches for AML are being actively developed. CARs promote immune reactions through recognition of the target molecular epitopes at the su...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Varvara Maiorova, Murad D. Mollaev, Polina Vikhreva, Elena Kulakovskaya, Dmitry Pershin, Dmitriy M. Chudakov, Alexey Kibardin, Michael A. Maschan, Sergey Larin
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	ligand-based targeting CAR T cell therapy acute myeloid leukemia Medicine R
Acceso en línea:	https://doaj.org/article/0af6a223b7c04eecb2755b3406e7a266
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

FLT3-ITD POSITIVITY IN AML; CASE SERIES
por: Kemal FİDAN
Publicado: (2021)

LY294002 Is a Promising Inhibitor to Overcome Sorafenib Resistance in FLT3-ITD Mutant AML Cells by Interfering With PI3K/Akt Signaling Pathway
por: Amin Huang, et al.
Publicado: (2021)

Survey of activated FLT3 signaling in leukemia.
por: Ting-lei Gu, et al.
Publicado: (2011)

Modulation of FLT3-ITD Localization and Targeting of Distinct Downstream Signaling Pathways as Potential Strategies to Overcome FLT3-Inhibitor Resistance
por: Maximilian Fleischmann, et al.
Publicado: (2021)

The correlation between Flt3-ITD mutation in dendritic cells with TIM-3 expression in acute myeloid leukemia
por: Hooriyeh Shapoorian, et al.
Publicado: (2021)

HSP70 and FLT3-ITD: Targeting chaperone system to overcome drug resistance
por: Jing Yang, et al.
Publicado: (2021)

Imipramine blue sensitively and selectively targets FLT3-ITD positive acute myeloid leukemia cells
por: Jonathan Metts, et al.
Publicado: (2017)

Inhibition of neuronal FLT3 receptor tyrosine kinase alleviates peripheral neuropathic pain in mice
por: Cyril Rivat, et al.
Publicado: (2018)

Actin cytoskeleton deregulation confers midostaurin resistance in FLT3-mutant acute myeloid leukemia
por: Andoni Garitano-Trojaola, et al.
Publicado: (2021)

Flt3 ligand treatment reduces enterovirus A71 lethality in mice with enhanced B cell responses
por: Yu-Wen Lin, et al.
Publicado: (2018)

FLT3-ITD transduces autonomous growth signals during its biosynthetic trafficking in acute myelogenous leukemia cells
por: Kouhei Yamawaki, et al.
Publicado: (2021)

Human Cytomegalovirus Encodes a Novel FLT3 Receptor Ligand Necessary for Hematopoietic Cell Differentiation and Viral Reactivation
por: Lindsey B. Crawford, et al.
Publicado: (2018)

Small Molecule Inhibitors of MERTK and FLT3 Induce Cell Cycle Arrest in Human CD8<sup>+</sup> T Cells
por: Richard M. Powell, et al.
Publicado: (2021)

Chlorpromazine eliminates acute myeloid leukemia cells by perturbing subcellular localization of FLT3-ITD and KIT-D816V
por: Shinya Rai, et al.
Publicado: (2020)

Mesenchymal stem cell therapy induces FLT3L and CD1c+ dendritic cells in systemic lupus erythematosus patients
por: Xinran Yuan, et al.
Publicado: (2019)

DEVELOPING CONCEPTUAL AWARENESS OF THE FUTURE PROFESSION IN THE STUDENTS OF INTERNATIONAL RELATIONS THROUGH FLT
por: L. P. Kostikova
Publicado: (2013)

sFlt-1 and CA 15.3 are indicators of endothelial damage and pulmonary fibrosis in SARS-CoV-2 infection
por: Marilena Greco, et al.
Publicado: (2021)

Correlation between 25-Hydroxyvitamin D, sFlt-1, PLGF, and Hypertension in Pregnancy
por: Wei Wang, et al.
Publicado: (2021)

Neuronal sFlt1 and Vegfaa determine venous sprouting and spinal cord vascularization
por: Raphael Wild, et al.
Publicado: (2017)

Placental and maternal sFlt1/PlGF expression in gestational diabetes mellitus
por: Anna Maria Nuzzo, et al.
Publicado: (2021)

PARP1 PARylates and stabilizes STAT5 in FLT3-ITD acute myeloid leukemia and other STAT5-activated cancers
por: Anna J. Dellomo, et al.
Publicado: (2022)

Early assessment of the efficacy of temozolomide chemotherapy in experimental glioblastoma using [18F]FLT-PET imaging.
por: Thomas Viel, et al.
Publicado: (2013)

Activating FLT3 mutants show distinct gain-of-function phenotypes in vitro and a characteristic signaling pathway profile associated with prognosis in acute myeloid leukemia.
por: Hanna Janke, et al.
Publicado: (2014)

Increased LIGHT leading to sFlt-1 elevation underlies the pathogenic link between hydatidiform mole and preeclampsia
por: Takayuki Iriyama, et al.
Publicado: (2019)

HHEX is a transcriptional regulator of the VEGFC/FLT4/PROX1 signaling axis during vascular development
por: Sébastien Gauvrit, et al.
Publicado: (2018)

Pseudogene fms-related tyrosine kinase 1 pseudogene 1 (FLT1P1) cooperates with RNA binding protein dyskeratosis congenita 1 (DKC1) to restrain trophoblast cell proliferation and angiogenesis by targeting fms-related tyrosine kinase 1 (FLT1) in preeclampsia
por: Zhenjing Chi, et al.
Publicado: (2021)

Progesterone Induced Blocking Factor Reduces Hypertension and Placental Mitochondrial Dysfunction in Response to sFlt-1 during Pregnancy
por: Evangeline Deer, et al.
Publicado: (2021)

Serum Levels of PDGF, EGF, and sFlt-1 in Patients with Polycystic Ovary Syndrome and Their Predictive Effects on Pregnancy Outcomes
por: Jiefan Gao, et al.
Publicado: (2021)

The coordinated p53 and estrogen receptor cis-regulation at an FLT1 promoter SNP is specific to genotoxic stress and estrogenic compound.
por: Yari Ciribilli, et al.
Publicado: (2010)

piggyBac system to co-express NKG2D CAR and IL-15 to augment the in vivo persistence and anti-AML activity of human peripheral blood NK cells
por: Zhicheng Du, et al.
Publicado: (2021)

Innate Immune Mechanisms and Immunotherapy of Myeloid Malignancies
por: Sara Small, et al.
Publicado: (2021)

Cell Therapy for Colorectal Cancer: The Promise of Chimeric Antigen Receptor (CAR)-T Cells
por: Cristina Aparicio, et al.
Publicado: (2021)

Resveratrol inhibits release of soluble fms-like tyrosine kinase (sFlt-1) and soluble endoglin and improves vascular dysfunction – implications as a preeclampsia treatment
por: Natalie J. Hannan, et al.
Publicado: (2017)

Conventional Cytogenetic and Molecular Analysis in Acute Myeloid Leukemia (AML) and Their Association with Overall Survival
por: Shakeri S., et al.
Publicado: (2021)

Human herpesvirus 6 myelitis after chimeric antigen receptor T-cell therapy
por: Guy Handley, et al.
Publicado: (2021)

Early Myeloid Derived Suppressor Cells (eMDSCs) Are Associated With High Donor Myeloid Chimerism Following Haploidentical HSCT for Sickle Cell Disease
por: Deepali K. Bhat, et al.
Publicado: (2021)

From Hematopoietic Stem Cell Transplantation to Chimeric Antigen Receptor Therapy: Advances, Limitations and Future Perspectives
por: Elisaveta Voynova, et al.
Publicado: (2021)

Modulating immune responses to AAV by expanded polyclonal T-regs and capsid specific chimeric antigen receptor T-regulatory cells
por: Motahareh Arjomandnejad, et al.
Publicado: (2021)

Cytoplasmic NEAT1 Suppresses AML Stem Cell Self‐Renewal and Leukemogenesis through Inactivation of Wnt Signaling
por: Huiwen Yan, et al.
Publicado: (2021)

An Interesting Similarity of Bacillus Calmette-Guerin and Chimeric Antigen Receptor T Cells
por: Seyed Saeed Tamehri Zadeh, et al.
Publicado: (2020)